DÉRIVÉ DE LA QUINAZOLINE ET SON UTILISATION COMME INHIBITEUR DE L'APOPTOSE

• 收藏
• 分享

专利权人:

Linx Pharmaceutical Co.; Ltd.

发明人:

申请号：

EP12871851.7

公开号：

EP2924037A1

申请日:

2012.03.23

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The present invention relates to the new use and target of a compound of formula I such as terazosin. In particular, the present invention relates to the use of the compound of formula I in the preparation of drugs used as an apoptosis inhibitor or drugs for treating and/or preventing sepsis and the complications thereof. The present invention provides a new method and direction for inhibiting apoptosis and treating and/or preventing sepsis and the complications thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/